Unbiased Analysis of Today's Healthcare Issues
Along with my co-authors Jeff Sullivan, Jacki Chou, Michael Neely, Justin Doan, and Ross Maclean I am happy to announce to publication our paper “The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma” in Cancer Management and Research. The abstract is below. Objective: To examine how observed medication nonadherence to 2…
With the FDA’s introduction of new guidelines surrounding the use of real-world evidence (RWE) in medical device regulatory decisions, FDA Commissioner Scott Gottlieb advances the argument for the utility of RWE. In fact, the FDA is currently considering the role of RWE in evaluating pharmaceutical treatments. Despite much debate over what part RWE should play in…
That’s the title of my article released today in U.S. News and World Report. Here is an excerpt. A number of health care industry leaders are making big bets that the future of health care lies in precision medicine. This July, Dr. Priscilla Chan and Mark Zuckerberg donated $10 million to the University of California-San Francisco’s…
In a recent paper with Jeff Sullivan, Dana P. Goldman, and Thomas M. Gill in PLOS One, we try to answer this question. The paper’s abstract is below. Introduction Chronic diseases associated with aging, such as arthritis, frequently cause reduced mobility, pain and diminished quality of life. To date, research on the association between…
Below is the abstract for my most recent publication titled “Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers“. It is work with Suepattra G May, Anshu Shrestha, Charles Ruetsch, Nicole Gerlanc, Felicia Forma, Ainslie Hatch, Darius N Lakdawalla, and Jean-Pierre Lindenmayer.…
Quality of care often is seen as how physicians and other health care providers treat patients with a given disease. Accurately diagnosing the disease a patient has, however, is in almost all cases a necessary condition to provide high-quality treatment. Nevertheless, a physician’s ability to accurately diagnose a disease is rarely measured within exsting quality…
Along with co-authors Jeremy Schafer and Dominic Galante, I have a new paper out in JMCP this month. The abstract is below, but do read the whole piece here. BACKGROUND: Organizations such as the National Comprehensive Cancer Network, American Society of Clinical Oncology, Institute for Clinical and Economic Review, and Memorial Sloan Kettering have created…
For those attending the British Society for Rheumatology Annual Meeting in Birmingham, England, I will be giving a podium presentation on Wednesday, April 26 at 12pm BST titled “Economic Burden of Rheumatoid Arthritis is Higher for Anti-Citrullinated Protein Antibody-Positive Patients.” Come by Hall 6 to check it out along with other presentations in the Clinical and…
This week at the 2017 Academy of Managed Care Pharmacy (AMCP) conference, the Journal of Managed Care & Specialty Pharmacy (JMCP) announced its annual Award for Excellence. The award was established in 2002 “…to recognize an article that represents the best scholarly work in managed care pharmacy.” This year, the 2016 Award for Excellence went to…
Value in Health has a Special Issue on Value Assessment Frameworks. The issue includes one of my papers (co-authored with Taylor T. Schwartz, Tony Okoro, John A. Romley) titled Patient Versus Physician Valuation of Durable Survival Gains: Implications for Value Framework Assessments. The abstract is below. Background: Previous research indicates that patients value therapies that provide…